Concert Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CNCE and buy or sell other stocks, ETFs, and their options commission-free!

About CNCE

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). 

CEO
Roger D. Tung, PhD
CEORoger D. Tung, PhD
Employees
—
Employees—
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2006
Founded2006
Employees
—
Employees—

CNCE Key Statistics

Market cap
401.95M
Market cap401.95M
Price-Earnings ratio
-2.61
Price-Earnings ratio-2.61
Dividend yield
—
Dividend yield—
Average volume
2.51M
Average volume2.51M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$8.55
52 Week high$8.55
52 Week low
$2.66
52 Week low$2.66
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.